Medinotec files first audited financials: $720K revenue, $289K net loss for 9 months

Medinotec Inc.

Revenue $720,339, gross profit $420,197, net loss $289,077 for nine months ended Nov 30, 2022.
Total assets $5.09M (cash $2.85M), total liabilities $2.51M, deficit $766K, equity $2.58M.
Audited statements filed with OTC Markets in support of OTCQX application.
Operating cash flow negative $848K; financing generated $4.23M from stock ($3.47M) and debt ($931K).
Basic EPS $(0.00); long-term debt $2.33M; no allowance for doubtful accounts.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

Medinotec Inc. reported financial results for the nine months ended November 30, 2022.

Period: the nine months ended November 30, 2022
Result: reported results

Exact text from the filing

On February 8, 2023, we completed an audit of our consolidated balance sheet as of November 30, 2022 the related consolidated statement of operations, changes in stockholders’ equity and cash flow for the nine months ended November 30, 2022 and the related notes (collectively referred to as the "Financial Statements").

View on SEC.gov

Browse all earnings releases →

Medinotec Inc. filing history →

Source: SEC EDGAR

accession 0001663577-23-000065

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.